Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Endocrinology
|
June 20, 2002
Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells
Ronald J Bernardi, Candace S Johnson, Ruth A Modzelewski, et al.
Journal of Neuro-Oncology
|
September 7, 2007
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines
Ronald J Bernardi, Amanda R Lowery, Patrick A Thompson, et al.
Urology
|
September 17, 2002
Vitamin D receptor: a potential target for intervention
Candace S Johnson, Pamela A Hershberger, Ronald J Bernardi, et al.
Oncotarget
|
November 5, 2017
Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
Atreyi Dasgupta, Matteo Trucco, Nino Rainusso, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Anti-tumor activity of calcitriol: pre-clinical and clinical studies
Donald L Trump, Pamela A Hershberger, Ronald J Bernardi, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 21, 2007
Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments
Ivy Chung, Wei-Dong Yu, Adam R Karpf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2007
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
Marwan G Fakih, Donald L Trump, Josephia R Muindi, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
The Lancet. Haematology
|
January 30, 2023
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Claude Négrier, Johnny Mahlangu, Michaela Lehle, et al.
Cell
|
March 27, 2018
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
Laura Magill Sack, Teresa Davoli, Mamie Z Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Endocrinology
|
June 20, 2002
Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells
Ronald J Bernardi, Candace S Johnson, Ruth A Modzelewski, et al.
Journal of Neuro-Oncology
|
September 7, 2007
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines
Ronald J Bernardi, Amanda R Lowery, Patrick A Thompson, et al.
Urology
|
September 17, 2002
Vitamin D receptor: a potential target for intervention
Candace S Johnson, Pamela A Hershberger, Ronald J Bernardi, et al.
Oncotarget
|
November 5, 2017
Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
Atreyi Dasgupta, Matteo Trucco, Nino Rainusso, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Anti-tumor activity of calcitriol: pre-clinical and clinical studies
Donald L Trump, Pamela A Hershberger, Ronald J Bernardi, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 21, 2007
Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments
Ivy Chung, Wei-Dong Yu, Adam R Karpf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2007
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
Marwan G Fakih, Donald L Trump, Josephia R Muindi, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
The Lancet. Haematology
|
January 30, 2023
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Claude Négrier, Johnny Mahlangu, Michaela Lehle, et al.
Cell
|
March 27, 2018
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
Laura Magill Sack, Teresa Davoli, Mamie Z Li, et al.
Page
of 2